arrow
K

Keitaro Sofue

Kobe University
H指数:28
被引数:2,675

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Percutaneous thermal ablation for renal cell carcinoma: a comprehensive review of current evidence and future directions

经皮热消融治疗肾细胞癌:当前证据和未来方向的全面综述

2026-08-180
PRE
Intraindividual comparison of photon-counting detector CT and third-generation dual-source energy-integrating detector CT in multiphasic contrast-enhanced abdominal CT

个体内比较:光子计数探测器CT与第三代双源能量积分探测器CT在多期相对比增强腹部CT中的应用

2026-03-260
OAAI
Prospective Study of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma Based on Hepatobiliary Phase of Gd-EOB-DTPA-MRI

基于Gd-EOB-DTPA-MRI肝胆期的阿替利珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌的前瞻性研究

2026-03-010
OAAI
Prospective pilot study of functional assessment of the Sphincter of Oddi via cine-dynamic MRCP with selective inversion recovery pulse
2026-01-220
OAAI
Pancreatic solid pseudopapillary neoplasms in male patients exhibit different clinical and imaging features compared with those in female patients

胰腺实性假乳头状瘤在男性患者中表现出与女性患者不同的临床和影像学特征。

2025-12-010
PRE
Impact of intrahepatic lesions on lesion-specific response rates in patients with hepatocellular carcinoma treated with lenvatinib or immune checkpoint inhibitors

肝内病灶对接受仑伐替尼或免疫检查点抑制剂治疗的肝细胞癌患者病灶特异性应答率的影响

HPB
IF2.4
2025-11-150
PRE
Artificial superintelligence alignment in healthcare

医疗保健领域的人工超级智能对齐

2025-11-140
OAAI
Breast cancer imaging without gadolinium-based contrast agent: A review of current applications and future trends

乳腺癌成像无需钆对比剂:当前应用及未来趋势的综述

2025-11-070
PRE
Utility of Oncological Resectability Criteria in Recurrent Hepatocellular Carcinoma After Hepatectomy

肝切除术后复发性肝细胞癌中肿瘤可切除标准的实用性

2025-11-010
OA
Illuminating radiogenomic signatures in pediatric-type diffuse gliomas: insights into molecular, clinical, and imaging correlations. Part I: high-grade group

揭示儿科型弥漫性胶质瘤的放射基因组学特征:分子、临床及影像学关联的见解。第一部分:高级别组

2025-08-250
OAAI